サワイグループホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/11/10 | 5,090 | 5,100 | 5,020 | 5,020 | -70 | -1.4% | 64,900 |
| 2021/11/09 | 5,060 | 5,120 | 5,060 | 5,090 | +30 | +0.6% | 62,800 |
| 2021/11/08 | 5,090 | 5,090 | 5,050 | 5,060 | -10 | -0.2% | 66,100 |
| 2021/11/05 | 5,060 | 5,080 | 5,050 | 5,070 | ±0 | ±0% | 51,900 |
| 2021/11/04 | 5,090 | 5,090 | 5,030 | 5,070 | +30 | +0.6% | 138,600 |
| 2021/11/02 | 5,060 | 5,070 | 5,010 | 5,040 | -20 | -0.4% | 67,900 |
| 2021/11/01 | 5,090 | 5,090 | 5,010 | 5,060 | +40 | +0.8% | 110,100 |
| 2021/10/29 | 5,060 | 5,060 | 5,010 | 5,020 | -10 | -0.2% | 69,300 |
| 2021/10/28 | 5,070 | 5,090 | 5,020 | 5,030 | +30 | +0.6% | 85,300 |
| 2021/10/27 | 5,110 | 5,140 | 4,985 | 5,000 | -90 | -1.8% | 92,900 |
| 2021/10/26 | 5,100 | 5,110 | 5,080 | 5,090 | +30 | +0.6% | 47,300 |
| 2021/10/25 | 5,070 | 5,110 | 5,050 | 5,060 | +30 | +0.6% | 73,400 |
| 2021/10/22 | 5,020 | 5,070 | 5,000 | 5,030 | -40 | -0.8% | 84,700 |
| 2021/10/21 | 5,080 | 5,110 | 5,070 | 5,070 | +10 | +0.2% | 72,300 |
| 2021/10/20 | 5,070 | 5,090 | 5,020 | 5,060 | +50 | +1% | 75,700 |
| 2021/10/19 | 5,070 | 5,090 | 5,000 | 5,010 | +15 | +0.3% | 75,200 |
| 2021/10/18 | 5,100 | 5,100 | 4,970 | 4,995 | -105 | -2.1% | 100,500 |
| 2021/10/15 | 5,090 | 5,120 | 5,040 | 5,100 | +10 | +0.2% | 106,500 |
| 2021/10/14 | 5,100 | 5,130 | 5,070 | 5,090 | -60 | -1.2% | 63,700 |
| 2021/10/13 | 5,160 | 5,170 | 5,130 | 5,150 | ±0 | ±0% | 67,000 |
| 2021/10/12 | 5,160 | 5,180 | 5,140 | 5,150 | -50 | -1% | 77,400 |
| 2021/10/11 | 5,150 | 5,200 | 5,120 | 5,200 | +90 | +1.8% | 49,800 |
| 2021/10/08 | 5,180 | 5,240 | 5,060 | 5,110 | +30 | +0.6% | 227,900 |
| 2021/10/07 | 5,130 | 5,130 | 5,050 | 5,080 | ±0 | ±0% | 72,100 |
| 2021/10/06 | 5,070 | 5,130 | 5,050 | 5,080 | -30 | -0.6% | 77,200 |
| 2021/10/05 | 5,180 | 5,190 | 5,060 | 5,110 | -100 | -1.9% | 74,500 |
| 2021/10/04 | 5,200 | 5,210 | 5,120 | 5,210 | +60 | +1.2% | 70,200 |
| 2021/10/01 | 5,140 | 5,190 | 5,100 | 5,150 | -50 | -1% | 85,600 |
| 2021/09/30 | 5,200 | 5,230 | 5,160 | 5,200 | ±0 | ±0% | 79,300 |
| 2021/09/29 | 5,210 | 5,230 | 5,110 | 5,200 | -100 | -1.9% | 144,000 |
| 2021/09/28 | 5,300 | 5,340 | 5,270 | 5,300 | +10 | +0.2% | 129,000 |
| 2021/09/27 | 5,290 | 5,300 | 5,270 | 5,290 | +50 | +1% | 84,600 |
| 2021/09/24 | 5,230 | 5,270 | 5,210 | 5,240 | +110 | +2.1% | 85,400 |
| 2021/09/22 | 5,180 | 5,190 | 5,110 | 5,130 | -50 | -1% | 84,700 |
| 2021/09/21 | 5,150 | 5,210 | 5,120 | 5,180 | -40 | -0.8% | 76,600 |
| 2021/09/17 | 5,250 | 5,260 | 5,170 | 5,220 | -80 | -1.5% | 137,200 |
| 2021/09/16 | 5,270 | 5,300 | 5,230 | 5,300 | +80 | +1.5% | 65,500 |
| 2021/09/15 | 5,260 | 5,300 | 5,200 | 5,220 | -80 | -1.5% | 74,500 |
| 2021/09/14 | 5,290 | 5,320 | 5,260 | 5,300 | +60 | +1.1% | 93,200 |
| 2021/09/13 | 5,170 | 5,240 | 5,140 | 5,240 | +70 | +1.4% | 70,100 |
| 2021/09/10 | 5,160 | 5,190 | 5,140 | 5,170 | -20 | -0.4% | 113,900 |
| 2021/09/09 | 5,190 | 5,220 | 5,160 | 5,190 | -60 | -1.1% | 63,400 |
| 2021/09/08 | 5,270 | 5,370 | 5,220 | 5,250 | +20 | +0.4% | 171,000 |
| 2021/09/07 | 5,230 | 5,270 | 5,200 | 5,230 | ±0 | ±0% | 118,900 |
| 2021/09/06 | 5,150 | 5,250 | 5,140 | 5,230 | +140 | +2.8% | 122,800 |
| 2021/09/03 | 5,060 | 5,180 | 5,050 | 5,090 | +80 | +1.6% | 196,200 |
| 2021/09/02 | 4,985 | 5,030 | 4,980 | 5,010 | +10 | +0.2% | 87,400 |
| 2021/09/01 | 5,040 | 5,040 | 4,980 | 5,000 | +25 | +0.5% | 84,900 |
| 2021/08/31 | 4,985 | 5,030 | 4,965 | 4,975 | -45 | -0.9% | 108,000 |
| 2021/08/30 | 5,000 | 5,040 | 4,990 | 5,020 | +65 | +1.3% | 114,000 |
851～
900
件表示中 / 1000件
類似銘柄と比較する
現在ご覧いただいている「サワイＧＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サワイＧＨＤ | 203,300円 | +4.0% | +25.4% | 2.61% | 8.89倍 | 1.17倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ペプチド | 201,800円 | +5.0% | +1.5% | 0.00% | 17.33倍 | 4.61倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 科研薬 | 407,200円 | +30.5% | +111.0% | 4.67% | 11.48倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 379,500円 | +14.5% | -2.3% | 2.37% | 13.88倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム
